ARCHIVES

Groups’ Growth, Impact Shown by Five-Year Data

This article is from The Cancer Letter archive.

Vol. 04 No. 09 | March 3, 1978

Download PDF Visit The Full Archive

Related Articles

Contract Proposal Would Assess Outcomes Other Than Incidence, Response, Mortality

September 18, 1987

New Regimens May Benefit Multiple Myeloma Patients

January 28, 2005

$2-A-Pack Cigarette Tax A “Significant Deterrent,” NCAB Resolution Says

October 8, 1993

Zevalin Regimen Effective In Mantle Cell Lymphoma

January 30, 2004

FDA Approves Bexxar For Non-Hodgkin’s Lymphoma

June 27, 2003

ACOS Planning Patient Care Melanoma Study

August 4, 1989